LONDON, Nov. 8, 2017 /PRNewswire/ --
Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots ClinicsDownload the full report: https://www.reportbuyer.com/product/5184206Report DetailsThe Chinese Pharmaceutical market is expected to grow at a CAGR of 12.3% in the second half of the forecast period. The Chinese Pharmaceutical market reached $145.4bn in 2016, dominated by the Cardiovascular therapy area which held 13.6% share of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 253-page report you will receive 68 tables and 90 figures– all unavailable elsewhere.The 253-page report provides clear detailed insight into the Chinese Pharmaceutical market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope• Chinese Pharmaceutical market forecasts from 2017-2027This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by therapy area:- Cardiovascular: including specific revenue forecasts for Hypertension and Dyslipidaemia- Anticancer- Infectious Diseases- Diabetes- Respiratory: including specific revenue forecasts for Asthma and COPD- Central Nervous System: including specific revenue forecasts for Antidepressants- Autoimmune- OthersThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading product class:- Small Molecules: further broken down into Generics Drugs and Branded Drugs- Traditional Chinese Medicine- Biologics: further broken down into Biologics (branded), Vaccines and BiosimilarsThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading type of drug:- Generic Prescription Drugs- Over-the-Counter (OTC) Drugs- Patented Prescription DrugsThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket.This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by sales channel:- Hospitals- Retail Pharmacies- Grassroots ClinicsThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket.• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT) that influence the Chinese Pharmaceutical Market. It also analyses social, technological, economic and political factors (STEP) that influence the Chinese Pharmaceutical Market• Our study ranks and provides 2016 revenues as well as market share of the top 50 domestic Chinese Pharmaceutical companies and top 10 Multinational Pharmaceutical Companies that are the major players in the Chinese Pharmaceutical Market• Our study lists and discusses the leading domestic and multinational Contract Research Organizations (CRO) that dominate the Chinese Pharmaceutical Market.Download the full report: https://www.reportbuyer.com/product/5184206 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
Advertisement
Cardiovascular Diseases, Oncology, Respiratory Diseases, Infectious Diseases, Diabetes, CNS, Autoimmune Diseases, Hypertension, Dyslipidaemia, COPD, Asthma, Antidepressants, Small Molecules, Branded Drugs, Traditional Chinese Medicine, Biologics, Vaccines, Biosimilars, Generic Prescription Drugs, Over-the-Counter Drugs, Patented Prescription Drugs, Hospitals, Retail Pharmacies, Grassroots ClinicsDownload the full report: https://www.reportbuyer.com/product/5184206Report DetailsThe Chinese Pharmaceutical market is expected to grow at a CAGR of 12.3% in the second half of the forecast period. The Chinese Pharmaceutical market reached $145.4bn in 2016, dominated by the Cardiovascular therapy area which held 13.6% share of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 253-page report you will receive 68 tables and 90 figures– all unavailable elsewhere.The 253-page report provides clear detailed insight into the Chinese Pharmaceutical market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope• Chinese Pharmaceutical market forecasts from 2017-2027This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by therapy area:- Cardiovascular: including specific revenue forecasts for Hypertension and Dyslipidaemia- Anticancer- Infectious Diseases- Diabetes- Respiratory: including specific revenue forecasts for Asthma and COPD- Central Nervous System: including specific revenue forecasts for Antidepressants- Autoimmune- OthersThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading product class:- Small Molecules: further broken down into Generics Drugs and Branded Drugs- Traditional Chinese Medicine- Biologics: further broken down into Biologics (branded), Vaccines and BiosimilarsThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket. Moreover, this report discusses the drivers and restraints of each submarket.This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by leading type of drug:- Generic Prescription Drugs- Over-the-Counter (OTC) Drugs- Patented Prescription DrugsThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket.This report also breaks down the revenue forecast for the Chinese Pharmaceutical market by sales channel:- Hospitals- Retail Pharmacies- Grassroots ClinicsThis report lists and discusses the domestic pharmaceutical companies that dominate each submarket.• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT) that influence the Chinese Pharmaceutical Market. It also analyses social, technological, economic and political factors (STEP) that influence the Chinese Pharmaceutical Market• Our study ranks and provides 2016 revenues as well as market share of the top 50 domestic Chinese Pharmaceutical companies and top 10 Multinational Pharmaceutical Companies that are the major players in the Chinese Pharmaceutical Market• Our study lists and discusses the leading domestic and multinational Contract Research Organizations (CRO) that dominate the Chinese Pharmaceutical Market.Download the full report: https://www.reportbuyer.com/product/5184206 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/the-chinese-pharmaceutical-market-reached-1454bn-in-2016-dominated-by-the-cardiovascular-therapy-area-which-held-136-share-of-the-market-300552449.html
SOURCE ReportBuyer
